Prospective Registry Study of Neoadjuvant Chemoradiation in Conjunction With Liver Transplantation for Cholangiocarcinoma With Induction Gemcitabine, Followed by 3D Conformal Radiation With 5-FU as a Radiosensitizer, and Maintenance Xeloda Therapy Until Liver Transplantation.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Fluorouracil; Gemcitabine
- Indications Cholangiocarcinoma
- Focus Adverse reactions; Therapeutic Use
- 28 Jul 2021 Biomarkers information updated
- 13 Aug 2008 Planned end date for this trial is now 1 May 2015 as reported by ClinicalTrials.gov
- 31 Jul 2006 New trial record.